Newsletter Archive

61. 03.28.23 -- SPR Assays To The Assess Similarity Between Innovator And Biosimilar Versions of Nivolumab (Opdivo) 3/28/2023
    03/28/23 Drug Discovery Online Newsletter
62. 03.22.23 -- Optimize Product Life Cycles With A Collaborative Partnership Model 3/22/2023

    03/22/23 Drug Discovery Online Newsletter

63. 03.21.23 -- Tangential Flow Filtration For Laboratory And Process Development Applications 3/21/2023

    03/21/23 Drug Discovery Online Newsletter

64. 03.21.23 -- In 2023, What Trends Will Dominate Cybersecurity? 3/21/2023
    03/21/23 Drug Discovery Online Newsletter
65. 03.15.23 -- Antibody Variants Chromatography, And Mechanistic Modeling Trends 3/15/2023

    03/15/23 Drug Discovery Online Newsletter

66. 03.14.23 -- Automating Instrument Data Ingestion And Access To Accelerate Lab Productivity 3/14/2023
    03/14/23 Drug Discovery Online Newsletter
67. 03.13.23 -- Overcome Complex Protein Challenges With Optimized Expression Technologies 3/13/2023

    03/13/23 Drug Discovery Online Newsletter

68. 03.10.23 -- Enabling And Advancing RNA-LNP From Concept To Clinic 3/10/2023

    03/10/23 Drug Discovery Online Newsletter

69. 03.07.23 -- How Collaborative Value Engineering And Continuous Improvement Enhance The CDMO Relationship 3/7/2023
    03/07/23 Drug Discovery Online Newsletter
70. 03.06.23 -- Driving Sustainability In Spray Drying And Wastewater Treatment 3/6/2023

    03/06/23 Drug Discovery Online Newsletter